Steroid use in acute liver failure

Hepatology

Volumn 59, Issue 2, 2014, Pages 612-621

  Karkhanis, Jamuna ^a   Verna, Elizabeth C ^a   Chang, Matthew S ^a   Stravitz, R Todd ^b   Schilsky, Michael ^c,i,j   Lee, William M ^d,e   Brown, Robert S ^a   Ostapowicz, George A ^e   Schiødt, Frank V ^e   Polson, Julie ^e   Larson, Anne M ^f   Davern, Timothy ^g,h   McCashland, Timothy ^k   Eileen Hay, J ^l   Murray, Natalie ^m   Shaikh, A Obaid S ⁿ   Blei, Andres ^o   Zaman, Atif ^p   Han, Steven H B ^q   Fontana, Robert ^r   McGuire, Brendan ^s   Chung, Raymond T ^t   Smith, Alastair ^u   Brown, Robert ^v   Crippin, Jeffrey ^w   Harrison, Edwin ^x   Reuben, Adrian ^y   Munoz, Santiago ^z   Reddy, Rajender ^aa   Rossaro, Lorenzo ^ab   Satyanarayana, Raj ^ac   Hassanein, Tarek ^ad   Samuel, Grace ^ae   Lalani, Ezmina ^ae   Pezzia, Carla ^ae   Sanders, Corron ^ae   Reisch, Joan S ^af   Hynan, Linda S ^af   Smith, Janet P ^af   Webster, Joe W ^af   Murray, Mechelle ^af   more..

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j YALE UNIVERSITY   (United States)

^k UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^l MAYO CLINIC   (United States)

^m BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF PITTSBURGH   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p UNIVERSITY OF OREGON   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF MICHIGAN   (United States)

^s UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^t MASSACHUSETTS GENERAL HOSPITAL   (United States)

^u DUKE UNIVERSITY MEDICAL CENTER   (United States)

^v Och Spine at New York Presbyterian Hospitals   (United States)

^w WASHINGTON UNIVERSITY   (United States)

^x MAYO CLINIC   (United States)

^y MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^z ALBERT EINSTEIN MEDICAL CENTER   (United States)

^aa UNIVERSITY OF PENNSYLVANIA   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac MAYO CLINIC   (United States)

^ad UNIVERSITY OF CALIFORNIA   (United States)

^ae UNIVERSITY OF TEXAS   (United States)

^af NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; STEROID;

ACUTE LIVER FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE ACUTE LIVER FAILURE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDUCED ACUTE LIVER FAILURE; FEMALE; HEPATIC COMA; HUMAN; INDETERMINATE ACUTE LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS SURVIVAL; SURVIVAL; SURVIVAL PREDICTION;

ADRENAL CORTEX HORMONES; ADULT; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84893711001     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26678     Document Type: Article

References (24)

1. Polson J, Lee W. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.
2. Ostapowicz G, Fontana R, Schiodt F, Larsen A, Davern TJ, Han Sh, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;237:947-954.
3. Smith GC, Kenna JG, Wolf CR. Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet 1993;342:963-964.
4. Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, et al. and theAcute Liver Failure Study Group. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011;53:517-512.
5. Ware AJ, Jones RE, Shorey JW, Combes B. A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol 1974;62:130-133.
6. Randomised trial of steroid therapy in acute liver failure. Report from the European Association for the Study of the Liver (EASL). Gut 1979;20:620-623.
7. Rakela J, Mosley JW, Edwards VM, Govindarajan S, Alpert E. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci 1991;36:1223-1228.
8. Ichai P, Duclos-Vallée J, Guettier C, Hamida S, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007;13:996-1003.
9. Czaja AJ. Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: therapeutic brinksmanship and the point beyond salvation. Liver Transpl 2007;13:953-955.
10. Giannattasio A, D'Ambrosi M, Volpicelli M, Iorio R. Steroid therapy for a case of severe drug-induced cholestasis. Ann Pharmacother 2006;40:1196-1199.
11. Martinez-Odriozola P, Gutierrez-Macias A, Ibarmia-Lahuerta J, Munoz-Sanchez J. Meloxicam as a cause of drug-induced autoimmune hepatitis. Dig Dis Sci 2010;55:1191-1192.
12. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006;354:54-66.
13. Goldstein NS, Bayati N, Silverman AL, Gordon SC. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 2000;114:591-598.
14. Alla V, Abraham J, Siddiqui J, Raina D, Wu GY, Chalasani NP, et al. Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 2006;40:757-761.
15. Van Heyningen C. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe. Ann Clin Biochem 2005;42(Pt 5):402-404.
16. Gregory B, Larson AM, Reisch J, Lee WM;Acute Liver Failure Study Group. Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 2010;58:707-710.
17. Prakash O, Mumtaz K, Hamid S, Ali Shah SH, Wasim Jafri SM. MELD score: utility and comparison with King's College criteria in non-acetaminophen acute liver failure. J Coll Physicians Surg Pak 2012; 22492-22496.
18. Nikias G, Batts K, Czaja A. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994;21:866-871.
19. Kessler W, Cummings O, Eckert G, Chalasani N, Lumeng L, Kwo P. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004;2:625-631.
20. Turlin B, Slapak GI, Hayllar KM, Heaton N, Williams R, Portmann B. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg 1995;1:285-289.
21. Canbay A, Chen SY, Gieseler RK, Malago M, Karilova M, Gerken G, et al. Overweight patients are more susceptible for acute liver failure. Hepatogastroenterology 2005;52:1516-1520.
22. Schreiter T, Marquitan G, Darnell M, Sowa JP, Brocker-Preuss, M, Andersson TB, et al. An ex vivo perfusion system emulating in vivo conditions in non cirrhotic and cirrhotic human liver. J Pharmacol Exp Ther 2012;342:730-741.
23. Grant L, Rockey DC. Drug induced liver injury. Curr Opin Gastroenterol 2012;28:198-202.
24. Wree A, Dechene A, Herzer K, Hilgard P, Syn WK, Gerken G, et al. Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury. Digestion 2011;84:54-59.